CopyMark Law Group
4.9/5
Drawing for ART-IG

USPTO serial 79277183

ART-IG

Reviewed by CopyMark Law Group

Reg. 6696013Status 700Registered
Filing date
Status date
Registration date
Apr 12, 2022
Examiner
STOIDES, KATHERINE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ART-IG?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bassam N. Ibrahim

Bassam N. Ibrahim Buchanan Ingersoll & Rooney PC1737 King Street, Suite 500Alexandria, VA 22314UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, all for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities in humans, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produces antibodies, fragments of antibodies or derivatives of antibodies for medical and pharmaceutical useACTIVE—
042Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticalsACTIVE—
045Granting of licenses to others for the use of industrial property rights and copyrightACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 26, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 26, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 26, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 12, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 12, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 29, 2022GPNXNOTIFICATION PROCESSED BY IB—
Jan 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 5, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 20, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2021ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 6, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 6, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 6, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 28, 2021RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 18, 2021OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 30, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 30, 2021OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Oct 6, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 6, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Oct 6, 2020CNSLSUSPENSION LETTER WRITTEN—
Sep 8, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 8, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 8, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 31, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 31, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 31, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 31, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 31, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 27, 2020RFNTREFUSAL PROCESSED BY IB—
Mar 9, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 9, 2020RFRRREFUSAL PROCESSED BY MPU—
Feb 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2020MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 3, 2020DOCKASSIGNED TO EXAMINER—
Feb 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance